Kratom News

By the Kratom Thai Exports editorial team. Last reviewed: 16 October 2026. Important notice. Kratom Thai Exports supplies business buyers only (B2B). You must be 18 or older to use this site. The content on this page is for general market and research information. It is not medical advice and must not be used to diagnose, treat, cure or prevent any condition. These statements have not been evaluated by the U.S. Food and Drug Administration (FDA). Research findings are summarised from the cited sources and describe what those studies reported; they are not claims about any product we supply. Laws on kratom and its alkaloids, including 7-hydroxymitragynine (7-OH), differ by country, state and city and change often. Check the laws in your jurisdiction and with your import authority before buying, importing or selling. Short answer: On 15 October 2026, Georgia Attorney General Chris Carr publicly urged the General Assembly to pass, and the governor to sign, a default-ban law covering all kratom-derived products, with only a narrow list of approved products allowed. That is a policy push, not a new statute. As of this writing, Georgia has not enacted a statewide kratom ban. Buyers shipping into Georgia should treat the 2027 legislative session and the House blue-ribbon study committee as live risk monitors. What did Georgia’s attorney general say on 15 October 2026? In a guest column for The Atlanta Journal-Constitution, Carr wrote that the General Assembly should pass, and the governor should sign, “a default-ban law for all kratom-derived products, with a narrow list of approved products.” He framed retail kratom sold in gas stations, convenience stores and vape shops as the “next wave of the opioid crisis” and said products are marketed in ways that reach children and teens. The same day, WABE reported that Carr pressed for a complete statewide ban while speaking before a meeting of the Statewide Opioid Task Force at Georgia State University. WABE also noted that a bill to tighten Georgia’s kratom rules stalled in the last legislative session. Carr’s AJC column referenced two University of Mississippi student deaths in Oxford and said investigators recovered packaged kratom purchased from a retailer, while stating that full toxicology results were still pending. This article does not treat those deaths as settled causation; it reports what Carr and WABE published. Is kratom already banned in Georgia? No. A call for legislation is not the same as a ban in force. WABE reported that Georgia currently limits sales to people 21 and older and requires products to be kept behind the counter. Secondary legal summaries of the Kratom Consumer Protection Act (O.C.G.A. 16-13-120 to 16-13-122) describe additional product caps and synthetic-alkaloid restrictions; confirm the current annotated code and counsel advice before shipping. Separately, the Georgia House has a Blue-Ribbon Study Committee on Youth Exposure to Kratom and Retail-Available Substances. Its published mandate is to evaluate youth exposure and options to strengthen protections. Committee recommendations can shape bills in a later session even when no ban has passed yet. How this sits next to federal 7-OH actions Federal and state tracks move on different clocks. On 14 October 2026, DEA published a Federal Register notice of intent to temporarily place above-threshold 7-OH and mitragynine pseudoindoxyl (MGPI) in Schedule I. That notice is not yet a temporary scheduling order; the earliest order date cited in the notice is on or after 13 November 2026. Botanical leaf remains federally unscheduled as of this writing. See our earlier briefing: DEA 7-OH Schedule I notice of intent (14 October 2026). Carr’s Georgia push is broader than the federal threshold approach in tone: he is calling for a state default ban on kratom-derived products, not only high-7-OH formats. Buyers should not assume federal leaf status protects Georgia retail programs if the General Assembly later adopts Carr’s model. What this means for B2B buyers For importers, brands and distributors sourcing Thai leaf or powder: Georgia is not banned today. Do not halt lawful Georgia programs solely on the basis of an op-ed. Do re-check age, display, labeling and product-spec rules with Georgia counsel before the next shipment. Watch the 2027 session. An attorney general default-ban ask plus an active study committee is a classic setup for new bills. Assign someone to track committee notices and introduced text. Separate leaf, extract and 7-OH SKUs in planning. State proposals often treat concentrated or synthetic formats differently from botanical leaf. Keep SKU maps and COAs ready so you can respond fast if a bill draws that line. Destination compliance still beats origin paperwork. Thai ONCB export licences and pre-shipment notices do not override Georgia retail or scheduling rules. Pair Thai export docs with US destination counsel. See export documents and permits and how to source bulk kratom from Thailand. Multi-state networks need state matrices. A Georgia ban, if enacted later, would not by itself change federal scheduling or Thai export rules, but it would cut a large Southeast US retail channel. Model inventory and customer concentration risk now. What buyers should do next Read Carr’s AJC column and the WABE report linked below. Treat social summaries as secondary. Confirm current Georgia obligations for your SKUs with qualified counsel (age gates, display, labeling, alkaloid limits, synthetic bans). Monitor the House blue-ribbon committee page and any 2027 bill text before changing supplier contracts. Keep federal DEA timing on a separate tracker from state ban politics. Related: kratom legal status in Thailand, importer FAQ and contact our team. This article is general market and regulatory reporting for business buyers. It is not legal advice. Confirm current federal, state and Thai rules with qualified counsel before importing or selling. Frequently asked questions Did Georgia ban kratom on 15 October 2026? No. Carr published an opinion column and spoke publicly in favor of a default ban. No new statewide ban statute is reported in the coverage cited here. Current retail rules described by WABE still include an age-21 limit and behind-the-counter display. What ban model did Carr propose? Per the AJC

By the Kratom Thai Exports editorial team. Last reviewed: 15 October 2026. Important notice. Kratom Thai Exports supplies business buyers only (B2B). You must be 18 or older to use this site. The content on this page is for general market and research information. It is not medical advice and must not be used to diagnose, treat, cure or prevent any condition. These statements have not been evaluated by the U.S. Food and Drug Administration (FDA). Research findings are summarised from the cited sources and describe what those studies reported; they are not claims about any product we supply. Laws on kratom and its alkaloids, including 7-hydroxymitragynine (7-OH), differ by country, state and city and change often. Check the laws in your jurisdiction and with your import authority before buying, importing or selling. Short answer: On 14 October 2026 the U.S. Drug Enforcement Administration (DEA) published a Federal Register notice of intent to temporarily place 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI) in Schedule I when either substance alone, or both combined, exceeds set concentration or ratio thresholds. This is not yet a final scheduling order. A temporary order cannot issue before 13 November 2026. Botanical kratom leaf itself remains federally unscheduled. Concentrated 7-OH products are the clear target. What did DEA publish on 14 October 2026? DEA published document 2026-20943 (91 FR 65370), titled Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I. It is listed as a proposed amendment and notice of intent under 21 U.S.C. 811(h). The same day, DEA Diversion Control listed the PDF under What’s New. In a separate action in the same issue, DEA withdrew its earlier 7 July 2026 notice of intent that used a different 7-OH threshold. The August 26, 2026 temporary order that already placed MGPI (without a threshold), MGM-15 and MGM-16 in Schedule I remains in effect until it expires or a new temporary order replaces it. What thresholds would trigger Schedule I? Per the Federal Register notice and the HHS recommendation of 8 October 2026 (announced publicly on 9 October 2026), 7-OH and MGPI would be subject to Schedule I controls when either substance alone, or their combined amount if both are present, is: Greater than 1 mg per gram in solid forms (powders, capsules, other solids), or greater than 1 mg per milliliter in liquids; or When the mass of mitragynine divided by the mass of 7-OH, MGPI, or both combined is less than 100 to 1. HHS described this as a way to distinguish concentrated or enhanced products from botanical kratom that may contain only trace levels of these compounds (HHS, 9 October 2026; DOJ, 9 October 2026). The Federal Register text states that neither HHS nor DEA has found below-threshold levels safe for use. When could a temporary order take effect? Under 21 U.S.C. 811(h), DEA must wait at least 30 days after publishing the notice of intent. The notice states the temporary scheduling order will be published on or after 13 November 2026. Once issued, a temporary Schedule I placement typically lasts two years, with a possible one-year extension while permanent scheduling proceeds. Temporary orders under 811(h) are not subject to the usual notice-and-comment rulemaking process. Until that order is published, above-threshold 7-OH is not yet federally Schedule I under this new notice. Do not treat the notice of intent as a ban already in force. What does this mean for B2B buyers? For importers, brands and distributors sourcing from Thailand: Concentrated 7-OH products (isolates, high-dose tablets, shots and similar enhanced formats) sit squarely in the intended Schedule I scope once the temporary order issues. Plan inventory, labeling and supplier contracts accordingly. Do not assume goods in transit after the order date will clear. Botanical leaf and powder remain federally unscheduled as of this writing. Buyers who need alkaloid documentation should request lot COAs that report mitragynine and 7-OH so they can check concentration and the mitragynine:7-OH ratio against the published thresholds. FDA and import risk already apply. FDA continues to treat concentrated 7-OH as unlawful in foods and dietary supplements and has issued warning letters. Import Alert 54-15 still allows detention of kratom dietary supplements and bulk ingredients. Scheduling does not replace FDA food and drug rules. State law still matters. Several U.S. states ban or cap 7-OH independently of federal Schedule I timing. Confirm destination state rules before shipping. Thai export path. Commercial leaf exports from Thailand use the ONCB licence and pre-shipment notification framework. Extracts and concentrates sit outside the clear leaf pathway. See our guides on export documents and permits and how to source bulk kratom from Thailand. How does this relate to earlier 2026 actions? On 9 October 2026, DOJ and HHS announced that DEA would issue updated notices of intent reflecting a revised HHS threshold for 7-OH and MGPI. The 14 October Federal Register publication is that notice. FDA’s page on 7-OH products was updated to reference the same threshold language. Earlier in 2026, DEA had published a July notice of intent for 7-OH (now withdrawn) and an August temporary order for MGPI, MGM-15 and MGM-16. What should buyers do next? Read the primary Federal Register notice and the DOJ and HHS releases linked below. Do not rely on social media summaries alone. Ask counsel in your destination market how temporary Schedule I controls would affect your SKUs, especially any enhanced or extract formats. For leaf programs, align COA specs with mitragynine and 7-OH reporting and confirm your Thai exporter’s ONCB documentation is current. Watch for the temporary scheduling order on or after 13 November 2026 on the Federal Register and DEA Diversion Control pages. Related: kratom legal status in Thailand, importer FAQ and contact our team. This article is general market and regulatory reporting for business buyers. It is not legal advice. Confirm current federal, state and Thai rules with qualified counsel before importing or selling. Frequently asked questions Is 7-OH Schedule I in the United States today? Not